[1] Stolwijk C, Onna M, Boonen A, et al.Global prevalence of spondyloarthritis: A systematic review and Meta-regression analysis[J].Arthritis Care Res,2016,68(10):1320-1331.
[2] 中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2021,14(8):557-559.
[3] 陈付彩. 强直性脊柱炎病因学的研究进展[J].临床医药文献电子杂志,2017,4(55):10887.
[4] Martínez-Borra J, González S, López-Larrea C. Genetic factors predisposing to spondylarthropathies[J].Arthritis Rheum,2020,43(3) :485-492.
[5] Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins-The role of genes,HLA,and theenvironment[J].Arthritis Rheum,2017,40(10) :1823-1828.
[6] Zochling J, Bohl-Buhler MH, Baraliakos X, et al. Infectionand work stress are potential triggers of ankylosing spondylitis[J].Clin Rheumatol,2016,25(5): 660-666.
[7] Kebapcilar L, Bilgir O, Alacacioglu A, et al.Impaired hypothalamo-pitultary-adrenal axis in patients with ankylosing spondylitis[J].J Endocrinol Invest,2020,33(1):42-47.
[8] 刘彧. 强直性脊柱炎免疫遗传学发病机制的研究进展[J].中国临床医学,2019,26(1):117-119.
[9] 李强,王伟,王玉红,等.强直性脊柱炎患者早期诊断及免疫功能的研究[J].中国煤炭工业医学杂志,2000,3(11) :1090-1091.
[10] Ridley A, Hatano H, Wong-Baeza I, et al. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis[J].Arthritis Rheum,2016,68(4):901-914.
[11] Bowness P, Ridley A, Shaw J, et al.Th17 cells expressing KIR3DL2(+)and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis[J].J Immunol,2018,186(4):2672-2680.
[12] Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease[J]. Clin Rev Allergy Immunol,2017,42(1)102-111.
[13] Schittenhelm RB, Tc LKS, Wilmann PG, et al.Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes[J].Arthritis Rheum,2015,67(3) :702-713.
[14] Ellinghaus D, Jostins L, Spain SL, et al.Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci[J].Nat Genet,2016,48(5) :510-518.
[15] Delay ML, Turner MJ, Klenk EI, et al.HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats[J]. Arthritis Rheum,2019,60(9) :2633-2643.
[16] Goodall JC, Wu C, Zhang Y, et al.Endoplasmic reticulum stressinduced transcription factor,CHOP,is crucial for dendritic cell IL23 expression[J].Proc Natl Acad Sci USA,2017,107(41):17698-17703.
[17] Costello ME, Ciccia F, Willner D, et al.Intestinal dysbiosis in ankylosing spondylitis[J].Arthritis Rheum,2015,67(3) :686-691.
[18] Ansalone C, Utriainen L, Milling S, et al.Role of gut Inflammation in HLA-B27 transgenic rats alters the monocyte compartment and its osteoclastogenic potential[J].Arthritis Rheum,2017,69(9) :1807-1815.
[19] Park MC, Kim HW, Lee SW, et al.Defective autophagy activity and its association with spinal damage in patients with ankylosing spondylitis[J]. Joint Bone Spine Revue Du Rhumatisme,2016,84(5):583-587.
[20] Li X, Chen M, Zhang X, et al.Single nucleotide polymorphisms of autophagy-related 16-like 1 gene are associated with ankylosing spondylitis in females: A case-control study[J].Int J Rheum Dis, 2018, 21(1) :322-329.
[21] 阮小风,林慧,杜鹏,等.强直性脊柱炎的中西医研究进展[J].华南国防医学杂志,2019,33(3):221-222.
[22] Sieper J,Poddubnyy D.Axial spondyloarthritis[J].Lancet,2017,390(10089):73-84.
[23] Stolwijk C, Tubergen A, Castillo O, et al.Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: A systematic review and meta-analysis[J].Ann Rheum Dis,2015,74(12):65-73.
[24] Lambert R, Bakker P, Heihde D, et al.Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: Update by the ASAS MRI Workinggroup[J].Ann Rheum Dis,2016,75(10):1958-1963.
[25] Ward MM, Deodhar A, Gensler LS, et al.2019 Update of the American College of Rheumatology/ Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J].Arthritis Rheumatol, 2019,71(10):1599-1613.
[26] Tam LS, Wei JC, Aggarwal A, et al.2018 APLAR axial spondyloarthritis treatment recommendations[J].Int J Rheum Dis,2019,22(3):340-356.
[27] 姚海红,苏茵.关于中轴型脊柱关节炎使用肿瘤坏死因子抑制剂的最新建议[J].中华风湿病学杂志,2011,15(9):633.
[28] Sieper J, Poddubnyy D.New evidence on the management of_x0007_ spondyl oarthritis[J].Nat Rev Rheumatol,2016,12(5):282-295.
[29] 杜琳,高延征.强直性脊柱炎诊断及治疗新进展[J].中华实用诊断与治疗杂志,2019,33(7):629-631. |
粤公网安备 44011302000297号 